On July 24, 2026, the U.S. Department of Health and Human Services Office for Civil Rights (OCR) issued a final rule removing provisions that impose or exemplify liability based…
On July 24, 2026, the U.S. Department of Health and Human Services Office for Civil Rights (OCR) issued a final rule removing provisions that impose or exemplify liability based on disparate impact under regulations implementing Title VI of the Civil Rights Act of 1964. The rule marks a significant recalibration of federal civil rights enforcement, narrowing the scope of conduct that will draw HHS scrutiny and reshaping compliance expectations for the wide range of institutions that receive HHS funding, including hospitals, health systems, universities, research institutions, and state and local public health agencies.
Under the final rule, HHS clarifies that Title VI prohibits only intentional discrimination on the basis of race, color, or national origin. HHS has stated that it will not pursue disparate-impact claims against federal funding recipients, meaning that policies or practices that are facially neutral but produce statistically uneven outcomes across protected groups will no longer, standing alone, form the basis of a Title VI enforcement action by the agency. Investigations, resolution agreements, and compliance reviews conducted by OCR will instead focus on evidence of purposeful discriminatory conduct.
HHS has framed the rulemaking as an effort to align its regulations with governing Supreme Court precedent and with Executive Order 14281. Taken together, the agency's stated rationale and the substance of the amendments signal a meaningful shift in federal civil rights enforcement priorities, and they may prompt parallel reconsideration of related sub-regulatory guidance, policy statements, and enforcement manuals that previously reflected a disparate-impact framework.
Recipients of HHS funding should not, however, treat the rule as an all-clear on outcome-based analyses. Other federal statutes and regulations, as well as state civil rights laws, accreditation standards, and payer requirements, may continue to address disparities in access, treatment, and outcomes through distinct legal theories. Institutions should also anticipate that the rule may face legal challenge, and that private plaintiffs may pursue claims under alternative frameworks. A careful review of nondiscrimination policies, data collection practices, grievance procedures, and training materials is advisable to ensure alignment with the revised federal standard while preserving compliance with other applicable obligations.
This article is provided for general informational purposes only. Organizations should consult qualified counsel for advice tailored to their specific circumstances.